American Red Cross Apheresis Red Blood Cells, Leukocytes Reduced
Apheresis Red Blood Cells, Leukocytes Reduced were labeled as antigen negative but were collected from a donor who tested antigen positive.
Recall ended Sep 28, 2026. Still check yours.
Moderate risk
Taking it may cause temporary or medically reversible health problems. Serious harm is unlikely.
FDA Class II recall · How risk is rated
What happened
The American National Red Cross began a recall of Apheresis Red Blood Cells, Leukocytes Reduced on July 14, 2026, because the units were labeled as antigen negative but were collected from a donor who subsequently tested antigen positive. The FDA added the recall to its Enforcement Report and classified it on September 28, 2026, and the recall was in the FDA's weekly enforcement report on October 7, 2026.
Summary by Recall Canary from the FDA notice.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these product details with yours, then check the recall notice for any restrictions.
Apheresis Red Blood Cells, Leukocytes Reduced
Details
- Company began the recall
- Event ID
- 99791
- Company
- The American National Red Cross
- Hazard
- Labeling error
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
